zmat3 Search Results


93
Thermo Fisher gene exp zmat3 mm00494181 m1
Gene Exp Zmat3 Mm00494181 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zmat3/Gene+Exp%2E+Zmat3%2C+Mm00494181_m1/pmc12830816-413-24--1
Average 93 stars, based on 1 article reviews
gene exp zmat3 mm00494181 m1 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Proteintech zmat3
Zmat3, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zmat3/ZMAT3+Antibody/pmc07875932-81-23-25
Average 93 stars, based on 1 article reviews
zmat3 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

90
OriGene fugene
Fugene, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zmat3/PAG608+(ZMAT3)+(NM_022470)+Human+Tagged+ORF+Clone/bio_rxiv__630228-164-13-22
Average 90 stars, based on 1 article reviews
fugene - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp zmat3 hs01074692 m1
Gene Exp Zmat3 Hs01074692 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zmat3/Gene+Exp%2E+ZMAT3%2C+Hs01074692_m1/pmc03353943__pone__0037273__s002-1-56--1
Average 86 stars, based on 1 article reviews
gene exp zmat3 hs01074692 m1 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

88
Thermo Fisher gene exp zmat3 mm01292424 m1
a <t>Zmat3</t> mRNA expression in pre-leukemic Eµ-Myc B lymphoid cells 0, 6, 12 and 24 h following 5 Gy γ-irradiation (IR) or treatment with 10 µM Nutlin3a (Nut3a). Mean ± SEM. b Lymphoma-free survival of Eµ-Myc ( n = 23), Eµ-Myc ; Zmat3 +/ − ( n = 21) and Eµ-Myc ; Zmat3 −/ − ( n = 17) mice. Median lymphoma-free survival: Eµ-Myc : 125 days; Eµ-Myc ; Zmat3 +/− : 94 days; Eµ-Myc ; Zmat3 −/ − : 93 days. Eµ-Myc vs Eµ-Myc ; Zmat3 +/ − p = 0.0718; Eµ-Myc vs Eµ-Myc ; Zmat3 −/ − p = 0.3231. c The proportions of Ig + B cell lymphomas and pro-B/pre-B cell lymphomas in sick Eµ - Myc ; Zmat3 −/− ( n = 4) and sick Eµ - Myc ( n = 3) mice. No significant differences were observed; p = 0.5 calculated by two-tailed t -test. d Spleen, thymus and lymph node weight (grams) in sick Eµ-Myc ( n = 7), Eµ-Myc ; Zmat3 +/ − ( n = 15) and Eµ-Myc ; Zmat3 −/ − ( n = 9) mice at ethical endpoint. Mean ± SEM.
Gene Exp Zmat3 Mm01292424 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zmat3/Gene+Exp%2E+Zmat3%2C+Mm01292424_m1/pmc07575595-28-12-7
Average 88 stars, based on 1 article reviews
gene exp zmat3 mm01292424 m1 - by Bioz Stars, 2026-10
88/100 stars
  Buy from Supplier

92
ABclonal Biotechnology antibodies against zmat3
a <t>Zmat3</t> mRNA expression in pre-leukemic Eµ-Myc B lymphoid cells 0, 6, 12 and 24 h following 5 Gy γ-irradiation (IR) or treatment with 10 µM Nutlin3a (Nut3a). Mean ± SEM. b Lymphoma-free survival of Eµ-Myc ( n = 23), Eµ-Myc ; Zmat3 +/ − ( n = 21) and Eµ-Myc ; Zmat3 −/ − ( n = 17) mice. Median lymphoma-free survival: Eµ-Myc : 125 days; Eµ-Myc ; Zmat3 +/− : 94 days; Eµ-Myc ; Zmat3 −/ − : 93 days. Eµ-Myc vs Eµ-Myc ; Zmat3 +/ − p = 0.0718; Eµ-Myc vs Eµ-Myc ; Zmat3 −/ − p = 0.3231. c The proportions of Ig + B cell lymphomas and pro-B/pre-B cell lymphomas in sick Eµ - Myc ; Zmat3 −/− ( n = 4) and sick Eµ - Myc ( n = 3) mice. No significant differences were observed; p = 0.5 calculated by two-tailed t -test. d Spleen, thymus and lymph node weight (grams) in sick Eµ-Myc ( n = 7), Eµ-Myc ; Zmat3 +/ − ( n = 15) and Eµ-Myc ; Zmat3 −/ − ( n = 9) mice at ethical endpoint. Mean ± SEM.
Antibodies Against Zmat3, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zmat3/ZMAT3+Rabbit+pAb/pm39389516-136-24-32
Average 92 stars, based on 1 article reviews
antibodies against zmat3 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

N/A
Zmat3 Rat 4 unique 29mer shRNA constructs in retroviral untagged vector
  Buy from Supplier

N/A
Transient overexpression of ZMAT3 NM 152240 in HEK293T cells paraffin embedded 4 um sections controls for ICC IHC staining 5 slides per pack
  Buy from Supplier

N/A
Lenti ORF particles Zmat3 GFP tagged ORF Rat zinc finger matrin type 3 Zmat3 200ul 10 7 TU mL
  Buy from Supplier

N/A
zinc finger matrin-type 3, Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence
  Buy from Supplier

N/A
Standard format: Plasmid sent in bacteria as agar stab
  Buy from Supplier

Image Search Results


a Zmat3 mRNA expression in pre-leukemic Eµ-Myc B lymphoid cells 0, 6, 12 and 24 h following 5 Gy γ-irradiation (IR) or treatment with 10 µM Nutlin3a (Nut3a). Mean ± SEM. b Lymphoma-free survival of Eµ-Myc ( n = 23), Eµ-Myc ; Zmat3 +/ − ( n = 21) and Eµ-Myc ; Zmat3 −/ − ( n = 17) mice. Median lymphoma-free survival: Eµ-Myc : 125 days; Eµ-Myc ; Zmat3 +/− : 94 days; Eµ-Myc ; Zmat3 −/ − : 93 days. Eµ-Myc vs Eµ-Myc ; Zmat3 +/ − p = 0.0718; Eµ-Myc vs Eµ-Myc ; Zmat3 −/ − p = 0.3231. c The proportions of Ig + B cell lymphomas and pro-B/pre-B cell lymphomas in sick Eµ - Myc ; Zmat3 −/− ( n = 4) and sick Eµ - Myc ( n = 3) mice. No significant differences were observed; p = 0.5 calculated by two-tailed t -test. d Spleen, thymus and lymph node weight (grams) in sick Eµ-Myc ( n = 7), Eµ-Myc ; Zmat3 +/ − ( n = 15) and Eµ-Myc ; Zmat3 −/ − ( n = 9) mice at ethical endpoint. Mean ± SEM.

Journal: Cell Death & Disease

Article Title: Consequences of Zmat3 loss in c-MYC - and mutant KRAS -driven tumorigenesis

doi: 10.1038/s41419-020-03066-9

Figure Lengend Snippet: a Zmat3 mRNA expression in pre-leukemic Eµ-Myc B lymphoid cells 0, 6, 12 and 24 h following 5 Gy γ-irradiation (IR) or treatment with 10 µM Nutlin3a (Nut3a). Mean ± SEM. b Lymphoma-free survival of Eµ-Myc ( n = 23), Eµ-Myc ; Zmat3 +/ − ( n = 21) and Eµ-Myc ; Zmat3 −/ − ( n = 17) mice. Median lymphoma-free survival: Eµ-Myc : 125 days; Eµ-Myc ; Zmat3 +/− : 94 days; Eµ-Myc ; Zmat3 −/ − : 93 days. Eµ-Myc vs Eµ-Myc ; Zmat3 +/ − p = 0.0718; Eµ-Myc vs Eµ-Myc ; Zmat3 −/ − p = 0.3231. c The proportions of Ig + B cell lymphomas and pro-B/pre-B cell lymphomas in sick Eµ - Myc ; Zmat3 −/− ( n = 4) and sick Eµ - Myc ( n = 3) mice. No significant differences were observed; p = 0.5 calculated by two-tailed t -test. d Spleen, thymus and lymph node weight (grams) in sick Eµ-Myc ( n = 7), Eµ-Myc ; Zmat3 +/ − ( n = 15) and Eµ-Myc ; Zmat3 −/ − ( n = 9) mice at ethical endpoint. Mean ± SEM.

Article Snippet: Quantitative RT-PCR was performed using TaqMan probes (Thermo Fisher Scientific) for Zmat3 (Mm01292424_m1), Puma (Mm00519268_m1), p21 (Mm00432448_m1) and analyzed by the ΔΔCT method relative to HMBS (Mm01143545_m1).

Techniques: Expressing, Irradiation, Two Tailed Test

a Representative hematoxylin and eosin (H&E) staining of lungs from Zmat3 −/ − , littermate Zmat3 +/+ (wt) and p53 −/ − control mice aged 16-18 weeks. Scale, 200 μm. b Flow cytometric analysis of the lymphoid and myeloid cells present in the lungs from Zmat3 −/− ( n = 4), p53 −/ − ( n = 2) and wt ( n = 4) mice. Immune cell populations are normalized to wt control mice. c Growth analysis of primary cell lines derived from the lung epithelium of wt ( n = 8) , Zmat3 −/ − ( n = 8) and p53 −/ − ( n = 4) mice. Mean ± SEM. d Accumulative cell number following 8 passages of primary wt ( n = 8) , p53 − / − ( n = 4) and Zmat3 −/− ( n = 8) cell lines. Mean ± SD, **** p < 0.0001. e Representative light microscope images of Zmat3 +/+ (wt) , p53 −/− and Zmat3 −/ − cell lines 8 passages following their derivation. Scale, 10 μm.

Journal: Cell Death & Disease

Article Title: Consequences of Zmat3 loss in c-MYC - and mutant KRAS -driven tumorigenesis

doi: 10.1038/s41419-020-03066-9

Figure Lengend Snippet: a Representative hematoxylin and eosin (H&E) staining of lungs from Zmat3 −/ − , littermate Zmat3 +/+ (wt) and p53 −/ − control mice aged 16-18 weeks. Scale, 200 μm. b Flow cytometric analysis of the lymphoid and myeloid cells present in the lungs from Zmat3 −/− ( n = 4), p53 −/ − ( n = 2) and wt ( n = 4) mice. Immune cell populations are normalized to wt control mice. c Growth analysis of primary cell lines derived from the lung epithelium of wt ( n = 8) , Zmat3 −/ − ( n = 8) and p53 −/ − ( n = 4) mice. Mean ± SEM. d Accumulative cell number following 8 passages of primary wt ( n = 8) , p53 − / − ( n = 4) and Zmat3 −/− ( n = 8) cell lines. Mean ± SD, **** p < 0.0001. e Representative light microscope images of Zmat3 +/+ (wt) , p53 −/− and Zmat3 −/ − cell lines 8 passages following their derivation. Scale, 10 μm.

Article Snippet: Quantitative RT-PCR was performed using TaqMan probes (Thermo Fisher Scientific) for Zmat3 (Mm01292424_m1), Puma (Mm00519268_m1), p21 (Mm00432448_m1) and analyzed by the ΔΔCT method relative to HMBS (Mm01143545_m1).

Techniques: Staining, Control, Derivative Assay, Light Microscopy

a Schematic of experimental design. Kras LSL-G12D/+ (K) mice were crossed with p53 −/ − mice (KPnull) or Zmat3 −/ − mice (KZ). b Kaplan–Meier tumor-free survival analysis of K ( n = 6), KPnull ( n = 6) and KZ ( n = 12) mice following i.n. infection of Ad5-CMV-Cre virus. c Representative H&E staining and immunohistochemistry of Ki67, Nkx2.1/TTF-1 and Hmga2 in end-stage lung tumors from Kras G12D , Kras G12D ; p53 −/ − and Kras G12D ; Zmat3 −/ − mice. Scale, 100 μm.

Journal: Cell Death & Disease

Article Title: Consequences of Zmat3 loss in c-MYC - and mutant KRAS -driven tumorigenesis

doi: 10.1038/s41419-020-03066-9

Figure Lengend Snippet: a Schematic of experimental design. Kras LSL-G12D/+ (K) mice were crossed with p53 −/ − mice (KPnull) or Zmat3 −/ − mice (KZ). b Kaplan–Meier tumor-free survival analysis of K ( n = 6), KPnull ( n = 6) and KZ ( n = 12) mice following i.n. infection of Ad5-CMV-Cre virus. c Representative H&E staining and immunohistochemistry of Ki67, Nkx2.1/TTF-1 and Hmga2 in end-stage lung tumors from Kras G12D , Kras G12D ; p53 −/ − and Kras G12D ; Zmat3 −/ − mice. Scale, 100 μm.

Article Snippet: Quantitative RT-PCR was performed using TaqMan probes (Thermo Fisher Scientific) for Zmat3 (Mm01292424_m1), Puma (Mm00519268_m1), p21 (Mm00432448_m1) and analyzed by the ΔΔCT method relative to HMBS (Mm01143545_m1).

Techniques: Infection, Virus, Staining, Immunohistochemistry

a Representative low magnification H&E stained lungs of Kras G12D/+ (K), Kras G12D/+ ; p53 −/− (KPnull) and Kras G12D/+ ; Zmat3 −/− (KZ) mice 6- and 10-weeks following i.n. administration of Ad5-CMV-Cre. Scale, 1 mm. b Lesion classification in the lungs of K ( n = 4), KPnull ( n = 4) and KZ ( n = 5) mice 10 weeks following i.n. Ad5-CMV-Cre infection. c Wet weight (mg) of the left lung lobe of K ( n = 3), KPnull ( n = 3) and KZ ( n = 8) mice 6 weeks following i.n. Ad5-CMV-Cre infection. Violin plot indicates the median weight and distribution.

Journal: Cell Death & Disease

Article Title: Consequences of Zmat3 loss in c-MYC - and mutant KRAS -driven tumorigenesis

doi: 10.1038/s41419-020-03066-9

Figure Lengend Snippet: a Representative low magnification H&E stained lungs of Kras G12D/+ (K), Kras G12D/+ ; p53 −/− (KPnull) and Kras G12D/+ ; Zmat3 −/− (KZ) mice 6- and 10-weeks following i.n. administration of Ad5-CMV-Cre. Scale, 1 mm. b Lesion classification in the lungs of K ( n = 4), KPnull ( n = 4) and KZ ( n = 5) mice 10 weeks following i.n. Ad5-CMV-Cre infection. c Wet weight (mg) of the left lung lobe of K ( n = 3), KPnull ( n = 3) and KZ ( n = 8) mice 6 weeks following i.n. Ad5-CMV-Cre infection. Violin plot indicates the median weight and distribution.

Article Snippet: Quantitative RT-PCR was performed using TaqMan probes (Thermo Fisher Scientific) for Zmat3 (Mm01292424_m1), Puma (Mm00519268_m1), p21 (Mm00432448_m1) and analyzed by the ΔΔCT method relative to HMBS (Mm01143545_m1).

Techniques: Staining, Infection

a Growth analysis of primary cell lines derived from the lung epithelium of KPnull ( n = 8) and KZ ( n = 12) mice 10 weeks following i.n. Ad5-CMV-Cre infection. Mean ± SEM. b Accumulative cell number following 8 passages of primary KPnull ( n = 8) and KZ ( n = 12) cell lines. Mean ± SD, *** p < 0.0001. c Representative light microscope images of Kras G12D / p53 −/ − (KPnull) and Kras G12D / Zmat3 −/ − (KZ) cell lines 8 passages following their derivation. Scale, 10 μm. d Schematic representation of p53 target genes and their role in tumor suppression.

Journal: Cell Death & Disease

Article Title: Consequences of Zmat3 loss in c-MYC - and mutant KRAS -driven tumorigenesis

doi: 10.1038/s41419-020-03066-9

Figure Lengend Snippet: a Growth analysis of primary cell lines derived from the lung epithelium of KPnull ( n = 8) and KZ ( n = 12) mice 10 weeks following i.n. Ad5-CMV-Cre infection. Mean ± SEM. b Accumulative cell number following 8 passages of primary KPnull ( n = 8) and KZ ( n = 12) cell lines. Mean ± SD, *** p < 0.0001. c Representative light microscope images of Kras G12D / p53 −/ − (KPnull) and Kras G12D / Zmat3 −/ − (KZ) cell lines 8 passages following their derivation. Scale, 10 μm. d Schematic representation of p53 target genes and their role in tumor suppression.

Article Snippet: Quantitative RT-PCR was performed using TaqMan probes (Thermo Fisher Scientific) for Zmat3 (Mm01292424_m1), Puma (Mm00519268_m1), p21 (Mm00432448_m1) and analyzed by the ΔΔCT method relative to HMBS (Mm01143545_m1).

Techniques: Derivative Assay, Infection, Light Microscopy